Goldman Sachs Group Inc Monterey Bio Acquisition Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

May 14, 2024
BUY
$9.96 - $10.06 $157,567 - $159,149
15,820 New
15,820 $158,000
Q1 2022

May 16, 2022
BUY
$9.85 - $9.96 $155,827 - $157,567
15,820 New
15,820 $158,000

About Monterey Bio Acquisition Corp

MTRY Quotes by TradingView
  • Ticker MTRY
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 14,375,000
  • Description
  • Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and change...
More about MTRY
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email